RxDoctor Payments Data

Maggie Garcia

Interventional Pain Medicine · Jacksonville, FLNPI 1811351638

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 75.9% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $15,859, more than ten times the $1,030 reported in 2020.

$21,710in general payments, 2019–2025

Across 208 payments — averaging $104.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$16K
  • Abbott$2K
  • Medtronic$846
  • Painteq LLC$417
  • Nevro Corp.$384
  • Vertos Medical, Inc.$383
  • plus $1K from 14 others

What the payments were for

  • Speaking & faculty fees$12,11356%
  • Travel & lodging$1,6918%
  • Food & beverage$7,70635%
  • Education$2001%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,710 in reported general payments places this provider in the 85th percentile of 278 interventional pain medicine providers in Florida.

See all interventional pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$512,190
Medicare patients
469
Services billed
10,410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine43$3,206
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen141$2,888
Pregabalin190$2,502
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen75$1,482
Gabapentin107$826
Tizanidine Hcl39$726
Meloxicam164$584
Methylprednisolone73$446
Buprenorphine Hcl15$438
Cyclobenzaprine Hcl27$400
Duloxetine Hcl33$379
Oxycodone Hcl28$360
Methocarbamol22$281
Tramadol Hcl39$167
Celecoxib18$121

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →